Kesarwani, Meenu
Kincaid, Zachary
Azhar, Mohammad
Menke, Jacob
Schwieterman, Joshua
Ansari, Sekhu
Reaves, Angela
Deininger, Michael E. http://orcid.org/0000-0002-2987-1331
Levine, Ross http://orcid.org/0000-0002-7884-1905
Grimes, H. Leighton
Azam, Mohammad http://orcid.org/0000-0002-3019-2221
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (RO1CA211594, RO1CA250516)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 5 February 2023
Revised: 11 June 2023
Accepted: 27 June 2023
First Online: 10 July 2023
Competing interests
: MA is a recipient of the bridge award from the American society of hematology (ASH). RLL is on the supervisory board of Qiagen and is a scientific advisor to Imago, Mission Bio, Bakx, Zentalis, Ajax, Auron, Prelude, C4 Therapeutics and Isoplexis. He has received research support from Abbvie, Constellation, Ajax, Zentalis and Prelude. He has received research support from and consulted for Celgene and Roche and has consulted for Syndax, Incyte, Janssen, Astellas, Morphosys and Novartis.